A single center, randomized, double blind, in parallel clinical study to compare pharmacokinetics profile of testing drug to originator, with a single dose of Restructuring of vascular endothelial growth factor humanized monoclonal antibody injection and Beacizumab in healthy adult male volunteers

Trial Profile

A single center, randomized, double blind, in parallel clinical study to compare pharmacokinetics profile of testing drug to originator, with a single dose of Restructuring of vascular endothelial growth factor humanized monoclonal antibody injection and Beacizumab in healthy adult male volunteers

Recruiting
Phase of Trial: Phase I

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Cancer
  • Focus Pharmacokinetics
  • Sponsors Genor Biopharma
  • Most Recent Events

    • 18 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top